REGENERON PHARMACEUTICALS, INC. Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2009-08-04: Form 10-Q; Exhibit 10.2; Description TRAP-2 TERMINATION AGREEMENT BY AND BETWEEN NOVARTIS PHARMA AG, NOVARTIS.
- 2009-08-04: Form 10-Q; Exhibit 10.1; Description IL-1 ANTIBODY AGREEMENT BY AND BETWEEN NOVARTIS PHARMA AG, NOVARTIS.
- 2009-04-30: Form 10-Q; Exhibit 10.3; Description THIRD AMENDMENT TO LEASE, BY AND BETWEEN BMR-LANDMARK.
- 2009-04-30: Form 10-Q; Exhibit 10.2; Description FORM OF OPTION AGREEMENT AND RELATED NOTICE OF GRANT FOR USE IN CONNECTION.
| Filed | Form | Exhibit | Description |
|---|
| 2009-08-04 | 10-Q | 10.2 | TRAP-2 TERMINATION AGREEMENT BY AND BETWEEN NOVARTIS PHARMA AG, NOVARTIS |
|---|
| 2009-08-04 | 10-Q | 10.1 | IL-1 ANTIBODY AGREEMENT BY AND BETWEEN NOVARTIS PHARMA AG, NOVARTIS |
|---|
| 2009-04-30 | 10-Q | 10.3 | THIRD AMENDMENT TO LEASE, BY AND BETWEEN BMR-LANDMARK |
|---|
| 2009-04-30 | 10-Q | 10.2 | FORM OF OPTION AGREEMENT AND RELATED NOTICE OF GRANT FOR USE IN CONNECTION |
|---|
| 2009-04-30 | 10-Q | 10.1 | FORM OF OPTION AGREEMENT AND RELATED NOTICE OF GRANT FOR USE IN CONNECTION |
|---|
| 2009-02-26 | 10-K | 10.5 | REGENERON PHARMACEUTICALS, INC. CHANGE IN CONTROL SEVERANCE PLAN |
|---|
| 2009-02-26 | 10-K | 10.3 | AMENDED AND RESTATED EMPLOYMENT AGREEMENT, DATED AS OF NOVEMBER 14, 2008 |
|---|